EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis

Shiyu Liao, Lan Shen

Frontiers in Cellular and Infection Microbiology · 04.06.2026 · 16

DOI: 10.3389/fcimb.2026.1804539 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 04.06.2026. Verfasst von Shiyu Liao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Yueyang Municipal Hospital of Hunan Normal University, Yueyang, Hunan, China. Hauptthemen laut MEDLINE: Sulbactam, Colistin, Acinetobacter baumannii, Anti-Bacterial Agents. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal combination therapy for carbapenem-resistant Acinetobacter baumannii (CRAB) pneumonia remains controversial. This study aimed to compare the microbiological efficacy, clinical outcomes, and safety of colistin-sulbactam versus colistin-tigecycline regimens in patients with CRAB hospital-acquired or ventilator-associated pneumonia (HAP/VAP).

Methods

A single-center, retrospective cohort study was conducted from 2019 to 2024. Adult patients with culture-confirmed CRAB HAP/VAP receiving either colistin-sulbactam (Group A) or colistin-tigecycline (Group B) for ≥72 hours were included. Propensity score matching (PSM) was utilized to balance baseline covariates, including APACHE II scores and renal function. The primary endpoint was microbiological eradication at Day 7; secondary endpoints included 28-day all-cause mortality, clinical cure, and adverse events.

Results

Among 176 eligible patients, 42 matched pairs (n=84) were generated. The colistin-sulbactam group achieved significantly higher microbiological eradication rates at Day 7 compared to the colistin-tigecycline group (66.7% vs. 40.5%; P = 0.013). Subgroup analysis revealed that this benefit was particularly pronounced in patients with extensively drug-resistant (XDR) strains (OR 4.75; 95% CI 1.58–14.26) and those with multisite colonization. Clinical cure rates were also higher in Group A (59.5% vs. 35.7%; P = 0.029). No significant difference was observed in 28-day all-cause mortality (31.0% vs. 38.1%; P = 0.490).

Conclusion

Colistin combined with high-dose sulbactam demonstrated higher microbiological clearance and clinical cure rates compared to colistin-tigecycline, particularly in patients with XDR strains and high bacterial burden. The sulbactam-based regimen offers a favorable efficacy and safety profile and should be considered a preferred therapeutic strategy for severe CRAB infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulbactamColistinAcinetobacter baumanniiAnti-Bacterial AgentsAcinetobacter InfectionsHealthcare-Associated PneumoniaHumansFemaleRetrospective StudiesMalePropensity ScoreAgedTreatment OutcomeMiddle AgedPneumonia, Ventilator-AssociatedDrug Therapy, CombinationCarbapenemsDrug Resistance, Multiple, BacterialAged, 80 and over

Stichwörter der Autor:innen

carbapenem-resistant Acinetobacter baumanniicolistinhospital-acquired pneumoniamultisite colonizationsulbactam

Substanzen

SulbactamColistinAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Department of Respiratory, Yueyang Municipal Hospital of Hunan Normal University, Yueyang, Hunan, China.
  • Department of Obstetrics, Yueyang Municipal Hospital of Hunan Normal University, Yueyang, Hunan, China.

Zitieren

APA

Liao, S., & Shen, L. (2026). Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1804539

Vancouver

Liao S, Shen L. Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1804539

BibTeX
@article{Liao2026,
  author = {Liao, Shiyu and Shen, Lan},
  title = {Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1804539}
}
Kostenlos starten →